NCT04920955View on ClinicalTrials.gov

Relapse Markers for Colorectal Cancer

CompletedOBSERVATIONAL
Enrollment

264

Participants

Timeline

Start Date

February 10, 2021

Primary Completion Date

December 31, 2023

Study Completion Date

January 31, 2024

Conditions
Colorectal Cancer
Trial Locations (1)

Unknown

Department of Gastroenterology, Digestive Oncology Unit, Leuven

Sponsors

Lead Sponsor

Novigenix SA
All Listed Sponsors
lead

Novigenix SA

OTHER

NCT04920955 - Relapse Markers for Colorectal Cancer | Biotech Hunter | Biotech Hunter